CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
EUTOMIC is developing a novel method to control the formation of pharmaceutical crystals using magnetic fields. This innovative approach aims to create new materials that can enhance drug formulation processes, potentially leading to a sustainable spin-off company focused on these advancements.
EUTOMIC presents a completely new and unexpected idea sprung from the cradle of the EU Horizon2020 FET-Open grant ‘MagnaPharm’ which is concerned with the control of polymorphism in pharmaceuticals through the application of strong magnetic fields.
The desire to control and constrain the growth of crystals using external stimuli in MagnaPharm led inexorably to the discovery of this new class of deep eutectics, using a sparingly stable synergistic solvent system as a vector for the spontaneous cr…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
